CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L306. A total of 21 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 1,077,465 | $3,179,000 | 0.56% |
DAFNA Capital Management LLC | 44,300 | $131,000 | 0.19% |
Perceptive Advisors | 350,000 | $1,033,000 | 0.10% |
Catalyst Capital Advisors LLC | 43,000 | $127,000 | 0.10% |
TANG CAPITAL MANAGEMENT LLC | 73,895 | $218,000 | 0.09% |
Invesco Private Capital | 116,316 | $343,000 | 0.04% |
Allianz Asset Management GmbH | 559,207 | $1,650,000 | 0.00% |
A.R.T. Advisors, LLC | 19,507 | $57,000 | 0.00% |
BARCLAYS PLC | 230,000 | $679,000 | 0.00% |
KNIGHT CAPITAL GROUP LLC | 26,263 | $77,000 | 0.00% |